Cargando…

Reply: Subgroup Differences in Response to 8 Weeks of Ledipasvir/Sofosbuvir for Chronic Hepatitis C

Detalles Bibliográficos
Autores principales: O’Brien, Thomas R., Pfeiffer, Ruth M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4567096/
https://www.ncbi.nlm.nih.gov/pubmed/26509180
http://dx.doi.org/10.1093/ofid/ofv057
_version_ 1782389775248916480
author O’Brien, Thomas R.
Pfeiffer, Ruth M.
author_facet O’Brien, Thomas R.
Pfeiffer, Ruth M.
author_sort O’Brien, Thomas R.
collection PubMed
description
format Online
Article
Text
id pubmed-4567096
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-45670962015-10-27 Reply: Subgroup Differences in Response to 8 Weeks of Ledipasvir/Sofosbuvir for Chronic Hepatitis C O’Brien, Thomas R. Pfeiffer, Ruth M. Open Forum Infect Dis Correspondence Oxford University Press 2015-04-20 /pmc/articles/PMC4567096/ /pubmed/26509180 http://dx.doi.org/10.1093/ofid/ofv057 Text en Published by Oxford University Press on behalf of the Infectious Diseases Society of America 2015. This work is written by (a) US Government employee(s) and is in the public domain in the US.
spellingShingle Correspondence
O’Brien, Thomas R.
Pfeiffer, Ruth M.
Reply: Subgroup Differences in Response to 8 Weeks of Ledipasvir/Sofosbuvir for Chronic Hepatitis C
title Reply: Subgroup Differences in Response to 8 Weeks of Ledipasvir/Sofosbuvir for Chronic Hepatitis C
title_full Reply: Subgroup Differences in Response to 8 Weeks of Ledipasvir/Sofosbuvir for Chronic Hepatitis C
title_fullStr Reply: Subgroup Differences in Response to 8 Weeks of Ledipasvir/Sofosbuvir for Chronic Hepatitis C
title_full_unstemmed Reply: Subgroup Differences in Response to 8 Weeks of Ledipasvir/Sofosbuvir for Chronic Hepatitis C
title_short Reply: Subgroup Differences in Response to 8 Weeks of Ledipasvir/Sofosbuvir for Chronic Hepatitis C
title_sort reply: subgroup differences in response to 8 weeks of ledipasvir/sofosbuvir for chronic hepatitis c
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4567096/
https://www.ncbi.nlm.nih.gov/pubmed/26509180
http://dx.doi.org/10.1093/ofid/ofv057
work_keys_str_mv AT obrienthomasr replysubgroupdifferencesinresponseto8weeksofledipasvirsofosbuvirforchronichepatitisc
AT pfeifferruthm replysubgroupdifferencesinresponseto8weeksofledipasvirsofosbuvirforchronichepatitisc